HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...
Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...
Get Instant Summarized Text (Gist) Ivarmacitinib, a selective JAK1 inhibitor, is effective and tolerable for adults with severe alopecia areata at doses of 4 mg and 8 mg. In a phase 3 trial, 34.9% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback